Basic Information
| RNALocate ID: | RLID:11004156 |
| RNA Symbol: | hsa-miR-877-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-877 |
| RNA ID: | miRBase:MIMAT0004949 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21505438 |
| Tissue/Cell Line: | Jurkat-derived T cell line (J77cl20) |
| Method: | Microarray |
| Description: | Microarray analysis of exosomal miRNAs verses the miRNAs of their respective donor cells. Data are collected from Supplementary Data 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002702 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002703 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002704 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11004154 | Exosome | Primary T lymphocytes | 24356509 |
| RLID:11004155 | Exosome | Pooled sera | 27278097 |
| RLID:11004157 | Exosome | K562 cells | 24460325 |
| RLID:11004158 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11004159 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000218 | Exosome | Lymphoma tissue | |
| RLID-D:11000725 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-877-5p | Oral squamous cell carcinoma | MNDR-E-MI-70048 |
| MNDR | hsa-miR-877-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-70049 |
| MNDR | hsa-miR-877-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-70050 |
| MNDR | hsa-miR-877-5p | Lymphoma | MNDR-E-MI-70051 |
| MNDR | hsa-miR-877-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-70052 |
| MNDR | hsa-miR-877-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-70053 |
| MNDR | hsa-miR-877-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-70054 |
| MNDR | hsa-miR-877-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-70055 |
| MNDR | hsa-miR-877-5p | Her2-receptor positive breast cancer | MNDR-E-MI-70056 |
| MNDR | hsa-miR-877-5p | Breast cancer luminal | MNDR-E-MI-70057 |
| MNDR | hsa-miR-877-5p | Prostate cancer | MNDR-E-MI-70058 |
| MNDR | hsa-miR-877-5p | Gastric cancer | MNDR-E-MI-70059 |
| MNDR | hsa-miR-877-5p | Alzheimer disease | MNDR-E-MI-70060 |
| MNDR | hsa-miR-877-5p | Esophageal carcinoma | MNDR-E-MI-70061 |
| MNDR | hsa-miR-877-5p | Huntington disease | MNDR-E-MI-70062 |
| MNDR | hsa-miR-877-5p | Chorea | MNDR-E-MI-70063 |
| MNDR | hsa-miR-877-5p | Cardiovascular disease | MNDR-E-MI-70064 |
| MNDR | hsa-miR-877-5p | Lung cancer | MNDR-E-MI-70065 |
| MNDR | hsa-miR-877-5p | Parkinson disease | MNDR-E-MI-70066 |
| MNDR | hsa-miR-877-5p | Basal-like breast cancer | MNDR-E-MI-70067 |
| MNDR | hsa-miR-877-5p | Pancreatic cancer | MNDR-E-MI-70068 |
| MNDR | hsa-miR-877-5p | Melanoma | MNDR-E-MI-70069 |
| MNDR | hsa-miR-877-5p | Rectum adenocarcinoma | MNDR-E-MI-70070 |
| MNDR | hsa-miR-877-5p | Nephroblastoma | MNDR-E-MI-70071 |
| MNDR | hsa-miR-877-5p | Colon cancer | MNDR-E-MI-70072 |
| MNDR | hsa-miR-877-5p | Colon adenocarcinoma | MNDR-E-MI-70073 |
| MNDR | hsa-miR-877-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-70074 |
| MNDR | hsa-miR-877-5p | Familial ovarian cancer | MNDR-E-MI-70075 |
| MNDR | hsa-miR-877-5p | Carcinoma ductal breast | MNDR-E-MI-70076 |
| MNDR | hsa-miR-877-5p | Glioblastoma | MNDR-E-MI-70077 |
| MNDR | hsa-miR-877-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-70078 |
| MNDR | hsa-miR-877-5p | Chordoma | MNDR-E-MI-70079 |
| MNDR | hsa-miR-877-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-70080 |
| MNDR | hsa-miR-877-5p | Osteosarcoma | MNDR-E-MI-70081 |
| MNDR | hsa-miR-877-5p | Breast carcinoma | MNDR-E-MI-70082 |
| MNDR | hsa-miR-877-5p | Liver cancer | MNDR-E-MI-70083 |
| MNDR | hsa-miR-877-5p | Gastric adenocarcinoma | MNDR-E-MI-70084 |
| MNDR | hsa-miR-877-5p | Lung squamous cell carcinoma | MNDR-E-MI-70085 |
| MNDR | hsa-miR-877-5p | Lung adenocarcinoma | MNDR-E-MI-70086 |
| MNDR | hsa-miR-877-5p | Thyroid carcinoma | MNDR-E-MI-70087 |
| MNDR | hsa-miR-877-5p | Ovarian carcinoma | MNDR-E-MI-70088 |
| MNDR | hsa-miR-877-5p | Bladder urothelial carcinoma | MNDR-E-MI-70089 |
| MNDR | hsa-miR-877-5p | Pancreatic adenocarcinoma | MNDR-E-MI-70090 |
| MNDR | hsa-miR-877-5p | Esophageal cancer | MNDR-E-MI-70091 |
| MNDR | hsa-miR-877-5p | Lung small cell carcinoma | MNDR-E-MI-70092 |
| MNDR | hsa-miR-877-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-70093 |
| MNDR | hsa-miR-877-5p | T acute lymphoblastic leukemia | MNDR-E-MI-70094 |
| MNDR | hsa-miR-877-5p | Acute t cell leukemia | MNDR-E-MI-70095 |
| MNDR | hsa-miR-877-5p | Adenoma | MNDR-E-MI-70096 |
| MNDR | hsa-miR-877-5p | Breast invasive carcinoma | MNDR-E-MI-70097 |
| MNDR | hsa-miR-877-5p | Hepatocellular carcinoma | MNDR-E-MI-70098 |
| MNDR | hsa-miR-877-5p | Familiar ovarian carcinoma | MNDR-E-MI-70099 |
| MNDR | hsa-miR-877-5p | Rheumatoid arthritis | MNDR-E-MI-70100 |
| MNDR | hsa-miR-877-5p | Malignant pleural mesothelioma | MNDR-E-MI-70101 |
| MNDR | hsa-miR-877-5p | Hodgkin lymphoma | MNDR-E-MI-70102 |
| MNDR | hsa-miR-877-5p | Colorectal cancer | MNDR-E-MI-70103 |
| MNDR | hsa-miR-877-5p | Nasopharynx carcinoma | MNDR-E-MI-70104 |
| MNDR | hsa-miR-877-5p | Nasopharyngeal cancer | MNDR-E-MI-70105 |
| MNDR | hsa-miR-877-5p | Stroke lacunar | MNDR-E-MI-70106 |
| MNDR | hsa-miR-877-5p | Breast cancer her3+ negative | MNDR-E-MI-70107 |
| MNDR | hsa-miR-877-5p | Tubulovillous adenoma | MNDR-E-MI-70108 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | EEF2K | Homo sapiens | RR00484494 |
TOP